GABAA receptor π forms channels that stimulate ERK through a G-protein-dependent pathway
Yueyue Wang1, Yalan Zhang2, Wenxue Li3
1Yale Cancer Biology Institute, Yale University, West Haven, CT 06516, USA; Breast Medical Oncology, Yale Cancer Center, Yale University School of Medicine, New Haven, CT 06520, USA.
Abstract:
The rare γ-aminobutyric acid type-A receptor (GABAAR) subunit π (GABRP) is highly expressed in certain cancers, where it stimulates growth through extracellular-regulated kinase (ERK) signaling by an uncharacterized pathway. To elucidate GABRP's signaling mechanism, we determined cryoelectron microscopy (cryo-EM) structures of GABRP embedded in native nanodiscs, both in the presence and absence of GABA. Structurally, GABRP homopentamers closely resemble heteropentameric GABAAR anion channels, transitioning from a closed "resting" state to an open "active" state upon GABA binding. However, functional assays reveal that GABRP responds more like a type-B metabotropic receptor. At physiological concentrations of GABA, chloride flux is not detected. Rather, GABRP activates a G-protein-coupled pathway leading to ERK signaling. Ionotropic activity is only triggered at supraphysiological GABA concentrations, effectively decoupling it from GABRP's signaling functions. These findings provide a structural and functional blueprint for GABRP, opening new avenues for targeted inhibition of GABA growth signals in GABRP-positive cancers.
Insights
The γ-aminobutyric acid type-A receptor subunit π (GABRP) activates cancer growth via G-protein-coupled pathways, not direct ion flow. Understanding its structure and function offers new cancer treatment targets.
Area of Science:
- Molecular and Cellular Biology
- Cancer Research
- Neuroscience
Background:
- The γ-aminobutyric acid type-A receptor subunit π (GABRP) is implicated in cancer growth.
- Its signaling pathway, particularly through extracellular-regulated kinase (ERK), remains uncharacterized.
Purpose of the Study:
- To determine the structural and functional mechanisms of GABRP signaling in cancer.
- To elucidate the pathway through which GABRP stimulates cancer growth.
Main Methods:
- Cryoelectron microscopy (cryo-EM) was used to determine the structures of GABRP in native nanodiscs.
- Functional assays were performed to assess GABRP's response to GABA binding.
Main Results:
- GABRP forms homopentamers structurally similar to other GABAARs, transitioning between closed and open states.
- GABRP primarily signals through a G-protein-coupled pathway to activate ERK, not via chloride flux at physiological GABA levels.
- Ionotropic activity was observed only at supraphysiological GABA concentrations.
Conclusions:
- GABRP functions akin to a metabotropic receptor, distinct from typical ionotropic GABAARs.
- The study provides a structural and functional basis for targeting GABRP in GABRP-positive cancers.
- Decoupling GABRP's growth signaling from its ionotropic function opens new therapeutic strategies.
Related Concept Videos
IP3/DAG Signaling Pathway
G-Protein Gated Ion Channels
Sensory...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Ligand-Gated Ion Channel Receptor: Gating Mechanism
GPCRs Regulate Adenylyl Cylase Activity
Amplifying Signals via Second Messengers


